A Phase I Trial of a Potent P-Glycoprotein Inhibitor, Zosuquidar.3HCl Trihydrochloride (LY335979), Administered Orally in Combination with Doxorubicin in Patients with Advanced Mal... von RUBIN, Eric H, DE ALWIS, Dinesh P, MUCH, Judy, KANE, Michael, CHAUDHARY, Ajai, JORDAN, Christopher, BURGESS, Michael, SLAPAK, Christopher A, POULIQUEN, Isabelle, GREEN, Lisa, MARDER, Phil, YONG LIN, MUSANTI, Rita, GROSPE, Stephanie L, SMITH, Sharon L, TOPPMEYER, Deborah L

Volltext

A phase I clinical trial of 12-O-tetradecanoylphorbol-13-acetate for patients with relapsed/refractory malignancies von SCHAAR, Dale, GOODELL, Lauri, MANAGO, Jacqueline, YONG LIN, RUBIN, Eric H, CONNEY, Allan, STRAIR, Roger K, AISNER, Joseph, XIAO XING CUI, ZHENG TAO HAN, CHANG, Richard, MARTIN, John, GROSPE, Stephanie, DUDEK, Liesel, RILEY, Joan

Volltext

A Pilot study of allogeneic cellular therapy for patients with advanced hematologic malignancies von Medina, Daniel J, Gharibo, Mecide, Savage, Philip, Cohler, Alan, Kuriyan, Mercy, Balsara, Binaifer, Anand, Monika, Schaar, Dale, Krimmel, Tracy, Saggiomo, Kara, Manago, Jacqueline, Talty, Lois, Dudek, Liesel, Grospe, Stephanie, Rubin, Arnold, Strair, Roger K

Volltext